Skip to main content
Figure 5 | BMC Pharmacology

Figure 5

From: Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling

Figure 5

SalB attenuates LV geometric changes induced by myocardial infarction. (A) Representative echocardiography recordings from each treatment group. n = 20 for every group. (B) Representative histopathological patterns of whole heart from different treatment groups. n = 10 for every group. (C) Higher magnification (100X) of Fig. 5B for the area indicated by arrows. (D, E) Quantitative data of LVAWd (D) or LVPWd (E) determined by echocardiography. (F, G) Quantitative data of LVAWd (F) or LVPWd (G) calculated using histopathology. *P < 0.05, ***P < 0.001 versus Sham rats; #P < 0.05, ###P < 0.001 versus MI rats.

Back to article page